Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis

BACKGROUND: The estimated prevalence of comorbid major depressive disorder (. MDD) is 11% in patients with type 2 diabetes (T2D) and 15–20% in those with cardiovascular disease (CVD). Comorbid MDD continues to be a significant source of economic burden to the healthcare system. METHODS: We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kangethe, Anne, Lawrence, Debra F., Touya, Maëlys, Chrones, Lambros, Polson, Michael, Evangelatos, Themmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349073/
https://www.ncbi.nlm.nih.gov/pubmed/34362353
http://dx.doi.org/10.1186/s12913-021-06802-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349073/
https://www.ncbi.nlm.nih.gov/pubmed/34362353
http://dx.doi.org/10.1186/s12913-021-06802-9

Ejemplares similares